Cite
HARVARD Citation
Rahmany, S. et al. (n.d.). P389 Switching infliximab to subcutaneous from intravenous therapy (SWIMSUIT) – A prospective, real-world, single centre, phase IV interventional study. Journal of Crohn's and colitis. pp. i522-i523. [Online].